Medical Cannabis in 2019:
Rapidly Emerging Clinical Evidence and Effects

Description

In the United States, medical marijuana has become officially legalized in 33 states and Washington D.C.: representing a collective population that currently exceeds the remainder of the country. Given the rapidly emerging popularity surrounding legalization in the United States, thousands of healthcare providers and clinicians live in geographical areas in which marijuana is legalized. More recently, an October 2018 survey conducted by Pew Research Center indicates that a growing number of Americans support marijuana legalization, with the 62% polled reflecting a steady increase over the past decade.

Healthcare practitioners receive daily questions from patients regarding medical marijuana, yet most remain unequipped to answer any specific queries—given the lack of education concerning clinical cannabis. Most clinicians have received little to no formal training on specific recommendations, dosage protocols, side effects product quality, and potential drug interactions: all critical aspects of patient care, when prescribing medical marijuana.

This medical marijuana workshop is designed to educate attendees—both the novices and regular prescribers—on a variety of medical marijuana-related topics, based on the latest scientific evidence and clinical research. Primary topics incorporated through the workshop's sessions will include the major phytocannabinoids, cannabidiol (CBD), and delta-9-tetrahydrocannabinol (Δ9-THC) found in marijuana and hemp plants. Given that both CBD and Δ9-THC yield unique interactions with the body's endocannabinoid system (ECS), lectures will demonstrate the ways in which phytocannabinoids modulate & influence a variety of physiological systems: including appetite, pain, inflammation, thermoregulation, sensation, muscle control, energy balance, metabolism, sleep hygiene, stress responses, motivation/reward, mood, and memory.

The symposium will conclude with an extended session, during which speakers and leaders from the cannabis industry will provide specific product updates, dosing recommendations, and answer specific “how to prescribe” questions.

Register

Medical Cannabis in 2019:
Rapidly Emerging Clinical Evidence and Effects

$599.00

ADD TO CART

Learning Objectives

Understand a variety of medical marijuana-related topics, based on the latest science and clinical research.
Define phytocannabinoids, cannabidiol (CBD), delta-9-tetrahydrocannabinol (Δ9-THC), and other extracts from the plant species cannabis sativa (from both hemp and marijuana subspecies).
Identify health-related applications of medical marijuana and interactions with the body's endocannabinoid system.
Review the latest clinical research on cancer, neurological, psychological, metabolic, and pain disorders using medical marijuana.